National Asset Management, Inc. Vaxart, Inc. Transaction History

National Asset Management, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 02, 2022	SELL	$4.29 - $6.64 $684,177 - $1.06 Million	-159,482 Closed	0 $0
Q4 2021 Jan 28, 2022	SELL	$5.77 - $7.96 $41,445 - $57,176	-7,183 Reduced 4.31%	159,482 $1 Million
Q3 2021 Nov 16, 2021	SELL	$6.67 - $9.8 $368,284 - $541,107	-55,215 Reduced 24.89%	166,665 $1.33 Million
Q2 2021 Aug 10, 2021	SELL	$5.06 - $10.78 $182,893 - $389,643	-36,145 Reduced 14.01%	221,880 $1.66 Million
Q1 2021 May 13, 2021	BUY	$5.64 - $23.33 $27,495 - $113,733	4,875 Added 1.93%	258,025 $1.56 Million
Q4 2020 Feb 04, 2021	BUY	$3.5 - $7.98 $247,289 - $563,818	70,654 Added 38.72%	253,150 $1.45 Million
Q3 2020 Nov 09, 2020	BUY	$4.78 - $16.97 $642,723 - $2.28 Million	134,461 Added 279.92%	182,496 $1.21 Million
Q2 2020 Jul 31, 2020	BUY	$1.68 - $8.85 $80,698 - $425,109	48,035 New	48,035 $426,000

110

37.6M

188K

180K

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $73.4M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

Get notified when there are updates to the investment portfolio of National Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on National Asset Management, Inc. with notifications on news.